Cargando…
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata). Design Data from two international, double blind, placebo controlled, r...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907480/ https://www.ncbi.nlm.nih.gov/pubmed/20647284 http://dx.doi.org/10.1136/bmj.c3493 |
Ejemplares similares
-
Vulvar intraepithelial neoplasia grade 3 associated with Behçet’s disease
por: Germann, Daphné, et al.
Publicado: (2016) -
Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
por: Righolt, Christiaan H., et al.
Publicado: (2022) -
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)
por: Madeleine, Margaret M., et al.
Publicado: (2016) -
Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia
por: He, Yue, et al.
Publicado: (2017) -
Early Diagnostics of Vulvar Intraepithelial Neoplasia
por: Kesić, Vesna, et al.
Publicado: (2022)